Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients. [electronic resource]
Producer: 20180101Description: 211-219 p. digitalISSN:- 1573-7373
- Adolescent
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Brain Neoplasms -- drug therapy
- Cohort Studies
- ErbB Receptors -- genetics
- Erlotinib Hydrochloride -- therapeutic use
- Everolimus -- therapeutic use
- Female
- Genomics -- methods
- Glioma -- drug therapy
- Humans
- Male
- Middle Aged
- Signal Transduction -- genetics
- TOR Serine-Threonine Kinases -- genetics
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.